europe
europe · page 4
- Medical
Panaxia and Neuraxpharm expand into Czech and Swiss markets
The pair will be expanding their co-operation through the distribution of medical cannabis products.
- Adult-Use
Cookies and Akanda: bringing premium cannabis genetics to Europe
Akanda CEO Tej Virk speaks to Cannabis Wealth about its new agreement to bring Cookies’ globally recognised genetics to the European market.
- Medical
Oral cannabis solution relaunched by Tilray in Ireland
The development gives Irish patients greater access to medical cannabis.
- Companies
Cannabis consulting firm aims to bring more business to European market
Higher Yields is embarking on its global expansion.
- Companies
Sanity Group closes Europe’s largest cannabis investment round
The Series B funding round closed at USD$37.6m (~£34.84m).
- Companies
Tilray authorised to import and distribute oral solution in Italy
Tilray Brands, Inc. has confirmed that FL Group S.R.L., a division of Tilray Medical in Italy, has received approval to import and distribute Tilray’s medical cannabis oral solution THC25 across the country.
- Adult-Use
Curaleaf completes majority stake acquisition of Four 20 Pharma
Curaleaf has stated that the deal solidifies its strategic advantage in Germany as the country prepares for an adult-use market.
- Companies
SEED Innovations company Eurox changes name to Avextra
German-based, vertically integrated cannabis company, Eurox, a SEED Innovations Limited portfolio company, has changed its name to Avextra.
- Adult-Use
How will Germany approach cannabis legalisation?
Bloomwell Group CEO, Niklas Kouparanis, spoke to Cannabis Wealth about the options Germany has for legalising adult use cannabis.
- Adult-Use
Akanda to bring Cookies branded products to Portugal
Akanada has signed an exclusive licensing agreement with the iconic US brand.
- Companies
Canonic to expand into Europe with first licensing agreement
The company has signed an agreement with GroVida licensing two of its cannabis varieties for cultivation and commercialisation in Europe
- Cultivation
Linneo Health receives EU-GMP Part I licence
The licence will enable the company to manufacture finished dosage forms, dried flowers and APIs.
